(Q33385836)

26 July 2017

1 reference

title

Thrombocytopenia and hemostatic disorders in chronic graft versus host disease (English)

1 reference

Chronic graft versus host disease

26 July 2017

1 reference

0 references

3

S Z Pavletic

1 reference

26 July 2017

D Pulanic

1

1 reference

26 July 2017

J N Lozier

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

17 August 2009

1 reference

Bone Marrow Transplantation

26 July 2017

published in

1 reference

26 July 2017

volume

44

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

393-403

1 reference

Optimistic expectations and survival after hematopoietic stem cell transplantation

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Transplantation's greatest challenges: advances in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Development of a prognostic model for grading chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Chronic graft-versus-host disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Impact of graft-versus-host disease on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Secondary failure of platelet recovery after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Mesenchymal stem cells: heading into the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Identification of the target platelet glycoprotein in autoimmune thrombocytopenia occurring after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Posttransfusion purpura following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Splenectomy for severe autoimmune cytopenias after allogenic stem cell transplantation: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Thrombocytopenia of sepsis. The role of circulating IgG-containing immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Vaccine strategies against human cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Life-threatening thrombocytopenia associated with acute Epstein-Barr virus infection in an older adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Human parvovirus B19-induced acquired pure amegakaryocytic thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Parvovirus B19 infection after transplantation: a review of 98 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Endothelial damage caused by cytomegalovirus and human herpesvirus-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

TGF- in allogeneic stem cell transplantation: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Thrombopoietin concentrations in peripheral blood correlated with platelet numbers in two patients with thrombocytopenia by chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Microparticles in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Serum-induced platelet procoagulant activity: an assay for the characterization of prothrombotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Thrombocytopenia caused by the development of antibodies to thrombopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Overview of thrombopoietic agents in the treatment of thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

B-cell involvement in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

Chronic graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Viruses and bone marrow failure

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Safety and efficacy of foscarnet for preemptive therapy against cytomegalovirus reactivation after unrelated cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Human parvovirus B19 associated with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Microparticles facilitate neutrophil/platelet crosstalk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.196

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.196

1 reference

Dimensions Publication ID

26 July 2017

1023053590

0 references

1 reference